Masimo Corporation (LON:0JZ2)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 5.63B |
| Revenue (ttm) | 1.63B |
| Net Income (ttm) | -424.60M |
| Shares Out | n/a |
| EPS (ttm) | -7.87 |
| PE Ratio | n/a |
| Forward PE | 24.54 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 88 |
| Average Volume | 276 |
| Open | 138.99 |
| Previous Close | 140.01 |
| Day's Range | 138.99 - 138.99 |
| 52-Week Range | 134.73 - 194.61 |
| Beta | 1.26 |
| RSI | 42.67 |
| Earnings Date | Feb 25, 2026 |
About Masimo
Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, methemoglobin, hemoglobin, fractional arter... [Read more]
News
Masimo Corporation (MASI) Analyst/Investor Day - Slideshow
HALPER SADEH LLC ENCOURAGES MASIMO CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK , Dec. 5, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is invest...
Masimo Pitches 2028 Plan With 30% Operating Margins
Masimo Corp (NASDAQ: MASI) on Wednesday hosted its 2025 Investor Day. At the event, Masimo’s management team provided an update on the company’s long-term strategy . Masimo also provided a detailed l...
Masimo Pitches 2028 Plan With 30% Operating Margins
Masimo Corp (NASDAQ: MASI) on Wednesday hosted its 2025 Investor Day. At the event, Masimo's management team provided an update on the company's long-term strategy.
Roku To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page . Needham r...
BTIG Raises Price Target for Masimo (MASI) to $200 | MASI Stock News
BTIG Raises Price Target for Masimo (MASI) to $200 | MASI Stock News
Masimo Corporation (MASI) Analyst/Investor Day Transcript
Masimo Corporation (MASI) Analyst/Investor Day December 3, 2025 12:00 PM ESTCompany ParticipantsMatthew BrinckmanCatherine Szyman - CEO & DirectorTim...
Masimo Outlines Long-term Strategy
(RTTNews) - Masimo (MASI) hosted its 2025 Investor Day at the company's headquarters, where management outlined its long-term strategy.
Masimo Hosts 2025 Investor Day and Details Strategic Roadmap for Durable Growth
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today hosted its 2025 Investor Day at the Company's headquarters. At the event, Masimo's management team provided an update on the Company's long...
Masimo (MASI) Q3 2025 Earnings Call Transcript
Masimo (MASI) Q3 2025 Earnings Call Transcript
Masimo (MASI) is an Incredible Growth Stock: 3 Reasons Why
Masimo (MASI) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Here's Why Masimo (MASI) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
BTIG Reiterates Buy Rating on MASI with $198 Price Target | MASI Stock News
BTIG Reiterates Buy Rating on MASI with $198 Price Target | MASI Stock News
9to5Mac Daily: November 18, 2025 – Apple vs Masimo drags on, iPadOS 26.2
Listen to a recap of the top stories of the day from 9to5Mac . 9to5Mac Daily is available on iTunes and Apple’s Podcasts app , Stitcher , TuneIn , Google Play , or through our dedicated RSS feed for O...
Knobbe Martens Guides Masimo to $634M Win Against Apple in Patent Infringement Case
IRVINE, Calif. , Nov. 18, 2025 /PRNewswire/ -- A team from Knobbe Martens led medical device pioneer Masimo (NASDAQ: MASI) to a victory over Apple in a dispute involving Masimo's patented heart monito...
DRC Congratulates Knobbe Martens on its $634 Million Win for Masimo
DRC congratulates Knobbe Martens on a decisive jury verdict awarding its client Masimo more than $634 million in an Apple Watch patent infringement case.
This Alto Neuroscience Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings pag...
Masimo (MASI): B of A Securities Initiates Coverage with Neutral Rating | MASI Stock News
Masimo (MASI): B of A Securities Initiates Coverage with Neutral Rating | MASI Stock News
Apple (AAPL) Faces New ITC Probe Over Masimo Patent Dispute
Apple (AAPL) Faces New ITC Probe Over Masimo Patent Dispute
Apple Ordered To Pay $634 Million After Jury Finds Company Infringed Masimo's Blood-Oxygen Sensor Patent
A federal jury in California has ruled that Apple Inc. (NASDAQ: AAPL) must pay Masimo Corporation (NASDAQ: MASI) $634 million for infringing a patent related to blood-oxygen reading technology. Masi...
4D Advisors Offloads $7.6 Million in Masimo (MASI) Stock, Selling 45,000 Shares
4D Advisors Offloads $7.6 Million in Masimo (MASI) Stock, Selling 45,000 Shares
Masimo (MASI) Secures $634 Million in Patent Infringement Case Against Apple
Masimo (MASI) Secures $634 Million in Patent Infringement Case Against Apple
Jury says Apple owes Masimo $634M for patent infringement
A federal jury in California ruled Friday that Apple must pay medical device maker Masimo $634 million for infringing a patent on blood oxygen monitoring technology.
Masimo (MASI) Wins $634M Patent Infringement Case Against Apple
Masimo (MASI) Wins $634M Patent Infringement Case Against Apple